학술논문
KEYNOTE-495/KEYIMPACT: UPDATED ANALYSIS OF A BIOMARKER-DIRECTED, RANDOMIZED, PHASE 2 TRIAL OF PEMBROLIZUMAB-BASED COMBINATION THERAPY FOR NON-SMALL CELL LUNG CANCER
Document Type
Journal
Author
Herbst, Roy; Lam, Wei-Sen; Hellmann, Matthew; Gubens, Matthew; Aggarwal, Charu; Tan, Daniel Shao Weng; Felip, Enriqueta; Chiu, Joanne; Lee, Jong-Seok; Yang, Names Chih-Hsin; Garon, Edward; Finocchiaro, Gioyanna; Ahn, Myung-Ju; Luft, Alexander; Landers, Gregory; Basso, Andrea; Ma, Hua; Kobie, Julie; Palcza, John; Cristescu, RaLvan; Fong, Lawrence; Snyder, Alexandra; Yuan, Jianda; Gutierrez, Martin
Source
Subject
Language
English
ISSN
20511426